Benzinga | Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals

0.0000 0 (%)

Data as of Dec 05, 2019

Prev. Close
Price Open
Volume 0
Day's Range -
52 Wk Range -
50 Day Moving Avg.
PE Ratio
Shares Outstanding
Market Cap

Trade SCLN stock with recommended broker Ally Invest. Commissions as low as $3.95.

Analyst Rating View All Ratings

Date	Research Firm	Action	Current	Target
11/29/16	Maxim Group	Initiates Coverage On	Buy
6/29/15	MLV & Co.	Initiates Coverage on	Buy	15.0
11/14/14	BWS Financial	Downgrades	BuyHold

33 Stocks Moving In Thursday's Mid-Day Session Lisa LevinThu, 12 Oct 2017 11:40:16 -0500
S&P Dow Jones Indices Reports 'NMI Holdings and Axcelis Technologies Set to Join S&P SmallCap 600' Paul QuintaroWed, 11 Oct 2017 16:18:15 -0500
SciClone Reports Q2 Adj. EPS $0.30 vs $0.24 Est., Sales $44.5M vs $43.4M Est. Paul QuintaroWed, 09 Aug 2017 15:29:20 -0500
Wall Street's M&A Chatter From June 8: Cabelas, SciClone Pharma, Microsoft-Hexadite, Athenahealth-Praxify Charles GrossFri, 09 Jun 2017 05:51:25 -0500
15 Biggest Mid-Day Gainers For Thursday Lisa LevinThu, 08 Jun 2017 11:28:55 -0500
22 Stocks Moving In Thursday's Pre-Market Session Lisa LevinThu, 08 Jun 2017 07:07:58 -0500
A Peek Into The Markets: U.S. Stock Futures Rise Ahead Of Jobless Claims Lisa LevinThu, 08 Jun 2017 06:28:10 -0500
SciClone Pharma to be Acquired by GL Capital for $11.18/Share Cash Paul QuintaroThu, 08 Jun 2017 05:01:50 -0500
SciClone Reports Q1 Adj. EPS $0.31 vs $0.14 Est., Sales $42.9M vs $39.9M Est. Paul QuintaroWed, 10 May 2017 15:46:15 -0500
20 Stocks Moving In Monday's Pre-Market Session Lisa LevinMon, 17 Apr 2017 07:24:04 -0500
{{ story.title }} {{ story.author }}{{ story.created }}

Show more Loading articles...

Consortium Led By GL Capital Completes Acquisition Of SciClone PRNewswireOct 13, 2017
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of SciClone Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 30, 2017 Business WireAug 29, 2017
SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of SciClone Pharmaceuticals, Inc. - SCLN PRNewswireAug 17, 2017
SciClone Announces End Of Go-Shop Period With No Parties Designated As Excluded Parties PRNewswireAug 10, 2017
SciClone Reports Second Quarter 2017 Financial Results PRNewswireAug 09, 2017
INVESTOR ALERT: Brower Piven Commences an Investigation into the Proposed Sale of SciClone Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm for Additional Information Business WireJun 19, 2017
SCICLONE INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of SciClone Pharmaceuticals, Inc. PRNewswireJun 19, 2017
INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Concerning Whether the Sale of SciClone Pharmaceuticals Inc. to a Consortium is Fair to Shareholders Business WireJun 15, 2017
SHAREHOLDER ALERT: Brower Piven Commences an Investigation into the Proposed Sale of SciClone Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm for Additional Information Business WireJun 13, 2017
SCICLONE PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Buyout Business WireJun 13, 2017
{{ story.title }} {{ story.author }}{{ story.created }}

Show more Loading articles...

Stonepine Capital Management, LLC Buys Viveve Medical Inc, Avadel Pharmaceuticals PLC, ... GuruFocusMay 15, 2017
SciClone Pharmaceuticals' (SCLN) CEO Friedhelm Blobel on Q4 2016 Results - Earnings Call Transcript Seeking AlphaMar 06, 2017
SciClone Pharmaceuticals reports Q4 results Seeking AlphaMar 06, 2017
SciClone Pharmaceuticals: Beyond The Death Of A Sales Process Seeking AlphaFeb 02, 2017
Adds and drops from the Nasdaq Biotech Index Seeking AlphaDec 13, 2016
Week In Review: Week's China Life Science Deals Total $795 Million Seeking AlphaNov 20, 2016
SciClone Pharmaceuticals' (SCLN) CEO Friedhelm Blobel on Q3 2016 Results - Earnings Call Transcript Seeking AlphaNov 11, 2016
SciClone Pharmaceuticals reports Q3 results Seeking AlphaNov 09, 2016
Valuation Dashboard: Healthcare - Update Seeking AlphaNov 09, 2016
Week In Review: Big Week For Cross-Border Life Science Deals Seeking AlphaOct 02, 2016
{{ story.title }} {{ story.author }}{{ story.created }}

Show more Loading articles...

Earnings View Earnings

Q2 2017	EST	Actual	Surprise
EPS:	0.24	0.3	0.06
Rev:	43.44M	44.52M	1.08M

	EST	Actual	Surprise
EPS:	Expected
Rev:	Expected

Brokerage Center

Compare All Online Brokerages

Market Overview

SciClone Pharmaceuticals, Inc. :

Analyst Rating View All Ratings

Earnings View Earnings

Brokerage Center

Popular Channels

Tools & Features

About Benzinga

Benzinga Partners

Membership is Free

What are you waiting for? Sign up now!

Free Account Login

Market Overview

Tickers

Articles

Keywords

SciClone Pharmaceuticals, Inc. :

Analyst Rating View All Ratings

Earnings View Earnings

Brokerage Center

Popular Channels

Tools & Features

About Benzinga

Benzinga Partners